Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

2.

Retreatment of tuberculosis patients in the city of Porto Alegre, Brazil: outcomes.

Picon PD, Rizzon CF, Bassanesi SL, Silva LC, Della Giustina Mde L.

J Bras Pneumol. 2011 Jul-Aug;37(4):504-11. English, Portuguese.

3.

[Adverse effects of the new tuberculosis treatment regimen recommended by the Brazilian Ministry of Health].

Maciel EL, Guidoni LM, Favero JL, Hadad DJ, Molino LP, Jonhson JL, Dietze R.

J Bras Pneumol. 2010 Mar-Apr;36(2):232-8. Portuguese.

4.
5.
6.

A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.

Jones BE, Otaya M, Antoniskis D, Sian S, Wang F, Mercado A, Davidson PT, Barnes PF.

Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1499-502.

PMID:
7952606
7.

[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].

Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.

Schweiz Med Wochenschr. 1989 Mar 11;119(10):299-305. German.

PMID:
2652281
8.

Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions.

Banu Rekha VV, Rajaram K, Kripasankar AS, Parthasarathy R, Umapathy KC, Sheikh I, Selvakumar N, Victor M, Niruparani C, Sridhar R, Jawahar MS.

Natl Med J India. 2012 Jul-Aug;25(4):196-200.

PMID:
23278775
9.

Adverse drug reactions observed during DOTS.

Dhingra VK, Rajpal S, Aggarwal N, Aggarwaln JK, Shadab K, Jain SK.

J Commun Dis. 2004 Dec;36(4):251-9.

PMID:
16506547
10.

Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.

Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.

Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9.

PMID:
12546119
11.

[Analysis of the treatment of pulmonary tuberculosis in elderly patients at a university hospital in Rio de Janeiro, Brazil].

Cantalice Filho JP, Bóia MN, Sant Anna CC.

J Bras Pneumol. 2007 Nov-Dec;33(6):691-8. Portuguese.

12.

Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.

Duarte R, Carvalho A, Correia A.

Public Health. 2012 Sep;126(9):760-2. doi: 10.1016/j.puhe.2012.04.008. Epub 2012 May 24. No abstract available.

PMID:
22633080
14.

Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.

Goldberg SV, Duchin JS, Shields T, Nolan CM.

Am J Respir Crit Care Med. 1999 Aug;160(2):508-12.

PMID:
10430721
15.

Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.

Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.

Trop Med Int Health. 2005 Nov;10(11):1090-8.

16.

Antituberculous agents.

Van Scoy RE, Wilkowske CJ.

Mayo Clin Proc. 1987 Dec;62(12):1129-36.

PMID:
3682957
17.

Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.

Morales S, Ramos W, Vílchez R, Pérez J, Alvarado M.

Neurologia. 2011 May;26(4):220-6. doi: 10.1016/j.nrl.2010.07.011. Epub 2010 Sep 28. English, Spanish.

18.

Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.

Guo N, Marra F, Fitzgerald JM, Elwood RK, Marra CA.

Eur Respir J. 2010 Jul;36(1):206-8. doi: 10.1183/09031936.00159409. No abstract available.

19.

[Directly observed treatment for tuberculosis in a Buenos Aires City hospital].

González C, Sáenz C, Herrmann E, Jajati M, Kaplan P, Monzón D.

Medicina (B Aires). 2012;72(5):371-9. Spanish.

20.

[Compliance, efficacy and tolerability of the therapeutic regimen recommended by National Consensus on Tuberculosis].

Colmenero JD, García-Ordoñez MA, Sebastián MD, Pérez-Ruiz E, Sánchez-Lora J, Sánchez-González J, Bentabol G, Juárez C.

Enferm Infecc Microbiol Clin. 1997 Mar;15(3):129-33. Spanish.

PMID:
9235051

Supplemental Content

Support Center